Conference transcripts and papers
Wolfgang Noe: Innovation to evolving cell culture based manufacturing processes / technology drivers and future perspectives
Arne Skerra: 'PASylation'...a superior technology to extend the plasma half-life of biologicals; The paradigm shift from antibodies to next generation biologics based on alternative protein scaffolds
Olivier Heudi: A rapid and accurate method for the quantitative analysis of monoclonal and antibodies and therapeutic proteins in biological fluids
Frédéric Legros: The EB66 cell line: a new solution for the production of biologics
Bernard Vanhove: Monovalent antagonist antibodies to block CD28-mediated costimulation
Yasmina Abdiche: Comparing the throughput of various label-free real-time biosensors in characterizing large panels of monoclonal antibodies
Titus Kretzschmar: Therapeutic Antibody Fragments - What for?
Syd Johnson: Fc‐Engineered and Bispecific Proteins for Oncology
David P Humphreys: Fab-Fv: an antibody fragment format with extended serum half life
Jijie Gu: Expression, Aggregation Profile & Preclinical Efficacies of DVD-Ig Molecules
Sara Gamberini: Microbial identification with genotypic methods – Continuous improvement to make them faster, cheaper, more accurate and GMP approved
Eric Ezan: Bioanalysis of therapeutic antibodies: Where do we stand?
Qingyu CAO: Immunogenicity Strategies for Antibody Therapeutics
Andrew Roberts: Bioanalytical support for therapeutic antibodies
Ullrich Haupts: Antibody Optimization based on HTP Screening
Jeff Evans: Developing Novel Targeted Cancer Therapies: Promises and Pitfalls
Celine Monnet: Engineering of the FC region of human antibodies to increase their serum half-life
Louise Cosby: Translating Academic Research into Effective Therapies Identification of Unknown Receptors Using Phage Antibody Display
Michael Rudolf: Pioneering the Use of Fully Human Antibodies to Fight Life-Threatening Infections
Ulrich Brinkmann: Recombinant bispecific tetravalent antibody derivatives for inhibition of HIV infection
Jens Herold: Trifunctional antibodies: Immunotherapeutics in cancer therapy
Melvyn Little: Tumor targeting with bispecific antibodies. Tetravalent TandAbs for recruiting immune effector cells
Anne Bondgaard Tolstrup: Cloning and Manufacturing of Antibody Mixtures for Infection and Cancer |